Sign in
4

Changes in Ownership

TherapeuticsMD, Inc. Filed Acc 0001209191-23-004871

Prin. Fin. and Acctg. Officer sold 1,309 shares at an average $5.34 ($6,988)

  • Prin. Fin. and Acctg. Officer acquired 4,365 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Donegan Michael C · Prin. Fin. and Acctg. Officer

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2023-01-23 Exercise or conversion : show line 1 in the form +380 4,934 D
2023-01-23 Exercise or conversion : show line 2 in the form +1,066 6,000 D
2023-01-23 Exercise or conversion : show line 3 in the form +519 6,519 D
2023-01-23 Exercise or conversion : show line 4 in the form +2,400 8,919 D
2023-01-23 Sale : show line 5 in the form −1,302 $5.34 $6,950 7,617 D
2023-01-24 Sale : show line 6 in the form −7 $5.31 $37 7,610 D
Open-market sales · 1,309 sh · avg $5.34 · $6,988

Table II: Derivative

4 lines
Date Transaction Shares Owned after D/I
2023-01-23 Exercise or conversion : show line 7 in the form Restricted Stock Units −380 0 D
2023-01-23 Exercise or conversion : show line 8 in the form Restricted Stock Units −1,066 0 D
2023-01-23 Exercise or conversion : show line 9 in the form Restricted Stock Units −519 0 D
2023-01-23 Exercise or conversion : show line 10 in the form Restricted Stock Units −2,400 0 D
Loading xslF345X03/doc4.xml…